Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × Dihematoporphyrin Ether × Clear all

Sponsor

Conditions

Lung Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma, Non-Small-Cell Lung 3 Head and Neck Neoplasms 2 Tongue Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrent Head and Neck Carcinoma 1 Precancerous Conditions 1 Pleural Effusion, Malignant 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Lymphoid Interstitial Pneumonia 1 Leukoplakia, Oral 1 Laryngeal Neoplasms 1 Barrett Esophagus 1

Interventions

Sorafenib 49 pembrolizumab 20 Nivolumab 18 Bevacizumab 16 Radiosurgery 15 Doxorubicin 12 lenvatinib 8 Erlotinib Hydrochloride 7 atezolizumab 6 Ramucirumab 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tremelimumab 5 durvalumab 5 cabozantinib 5 Radiofrequency Ablation 5 tislelizumab 4 Sunitinib 4 Ipilimumab 4 regorafenib 3 nintedanib 3 carotuximab 3 bavituximab 3 Ribavirin 3 Radiotherapy 3 Oxaliplatin 3 Mitomycin 3 Leucovorin 3 Fluorouracil 3 Everolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡